|
Delayed
Australian S.E.
03:46:13 02/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 8.370 AUD | +1.58% |
|
-20.44% | -32.83% |
| 28/08 | Morgans Financial Downgrades Clinuvel Pharmaceuticals to Hold from Speculative Buy; Price Target is AU$10 | MT |
| 28/08 | Clinuvel Pharmaceuticals Limited, 2026 Earnings Call, Aug 27, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.58% | -20.44% | -8.62% | -7.00% | -32.83% | -19.75% | -53.88% | -78.00% | +64.12% | 297M | |
| +3.10% | -1.17% | +8.02% | +37.15% | +6.73% | +41.87% | -0.94% | +20.98% | +109.41% | 82.26B | |
| +0.57% | +0.60% | +39.57% | +87.42% | +0.48% | -16.74% | -35.37% | -42.83% | +65.33% | 59.05B | |
| +9.93% | -2.87% | +181.41% | +234.93% | +423.13% | +540.39% | +37.06% | -60.44% | - | 61.59B | |
| +0.13% | -4.10% | +2.36% | +10.38% | -10.32% | -0.74% | +34.87% | +2.76% | - | 51.23B | |
| +1.49% | -2.50% | -1.97% | -14.04% | -8.42% | +9.69% | +163.06% | +125.54% | +204.06% | 48.3B | |
| -0.28% | -2.14% | +6.45% | +12.39% | +22.76% | +63.39% | -19.14% | -36.13% | -29.41% | 31.92B | |
| +1.45% | -3.63% | +4.59% | +30.78% | +26.57% | +47.75% | +93.24% | +62.29% | +54.70% | 25.34B | |
| -0.39% | -7.74% | +17.79% | +28.47% | +32.85% | -3.80% | +193.62% | +56.57% | - | 22.56B | |
| +1.69% | -2.60% | -2.80% | +5.34% | +37.44% | +61.63% | +116.78% | +138.60% | +357.40% | 16.56B | |
| -2.11% | -1.47% | +26.84% | +6.91% | -12.95% | -14.00% | +794.40% | +445.37% | +6,882.30% | 15.28B | |
| -0.03% | -4.76% | -4.40% | +17.15% | +0.10% | +47.93% | +150.39% | +51.20% | - | 14.97B | |
| -0.60% | -1.94% | +8.03% | +17.83% | +9.10% | +11.28% | -30.30% | -23.06% | -31.88% | 12.55B | |
| +1.25% | +2.15% | +6.66% | +22.05% | +47.58% | +146.34% | +188.19% | +491.99% | - | 10.77B | |
| +2.17% | -1.29% | -6.95% | -11.91% | +11.05% | +67.24% | +148.29% | +631.97% | +2,697.66% | 10.62B | |
| -4.99% | -12.79% | +44.25% | +94.61% | +316.33% | +389.66% | +460.53% | +12.83% | - | 8.28B | |
| +0.96% | -1.18% | -0.38% | +7.80% | -7.23% | -18.37% | -21.72% | -52.51% | -47.02% | 6.88B | |
| +0.83% | -1.15% | +6.65% | +63.70% | +92.19% | +136.73% | +346.40% | +518.89% | - | 6.19B | |
| +3.10% | +3.33% | +3.40% | +34.83% | +4.41% | -9.14% | +68.05% | -13.43% | - | 6.29B | |
| -1.57% | -3.52% | +2.77% | -6.78% | +2.06% | +14.82% | +206.44% | +199.94% | - | 5.59B | |
| Average | +0.86% | -3.62% | +16.68% | +33.60% | +48.05% | +74.81% | +142.00% | +122.63% | +938.79% | 24.83B | |
| Weighted average by Cap. | +2.02% | -2.72% | +31.73% | +53.48% | +64.82% | +95.13% | +86.23% | +58.27% | +524.77% |
- Stock Market
- Stocks
- CUV Stock
- Sector Clinuvel Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
